Key facts
- Axis Spine Technologies’s last known valuation is $31.5M (May 2025).
- It has raised $29.3M; the latest was Later Stage VC ($9.0M) in May 2025.
- Notable investors include Innovate UK, Mercia Ventures, ACF Investors, Enterprise Investment Scheme, MedTex Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Axis Spine Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Axis Spine Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Axis Spine Technologies
Developer of spinal implants designed to offer greater intra-operative correction capabilities without the risks associated with small moving parts that can wear out. The company focuses on reducing the risks of structural damage and under-reported and unrecognized complications, which can lead to subsidence, so implants are inserted with less force than conventional implants, enabling surgeons to provide precision-engineered spinal fusion and a sophisticated correction of the deformity.
- Sector
- Healthcare
- HQ
- Saint Albans, United Kingdom
- Founded
- 2016
- Employees
- 15
- Website
- axisspinetech.com/
- Ownership
- Privately Held (backing)
Axis Spine Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Axis Spine Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Axis Spine Technologies in its N-PORT filings yet. We sweep new filings monthly.